Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Verdonck

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Clinical Rheumatology|March 1, 1989
Multiple sites of ischemic necrosis of bone following long term corticosteroid treatment in a patient with auto-immune granulocytopeniaH J van Leeuwen, D Witkamp, L F Verdonck, et al.
Blood|May 15, 1994
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graftL F Verdonck, A W Dekker, G C de Gast, et al.
Bone Marrow Transplantation|March 1, 1989
Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovirL F Verdonck, G C de Gast, A W Dekker, et al.
Bone Marrow Transplantation|February 1, 1993
Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMTL F Verdonck, J J Cornelissen, J Smit, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemiaB Löwenberg, W L van Putten, A Ferrant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOPL F Verdonck, A W Dekker, G C de Gast, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON GroupG M Bos, W L van Putten, B van der Holt, et al.
British Medical Journal (Clinical Research Ed.)|January 25, 1986
Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virusJ M Lange, R A Coutinho, W J Krone, et al.
Leukemia|January 1, 1994
Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON)S Daenen, B Löwenberg, P Sonneveld, et al.
The Journal of Biological Chemistry|November 27, 1999
Cyclin D3 regulates proliferation and apoptosis of leukemic T cell linesG J Boonen, B A van Oirschot, A van Diepen, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Clinical Rheumatology|March 1, 1989
Multiple sites of ischemic necrosis of bone following long term corticosteroid treatment in a patient with auto-immune granulocytopeniaH J van Leeuwen, D Witkamp, L F Verdonck, et al.
Blood|May 15, 1994
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graftL F Verdonck, A W Dekker, G C de Gast, et al.
Bone Marrow Transplantation|March 1, 1989
Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovirL F Verdonck, G C de Gast, A W Dekker, et al.
Bone Marrow Transplantation|February 1, 1993
Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMTL F Verdonck, J J Cornelissen, J Smit, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemiaB Löwenberg, W L van Putten, A Ferrant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOPL F Verdonck, A W Dekker, G C de Gast, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON GroupG M Bos, W L van Putten, B van der Holt, et al.
British Medical Journal (Clinical Research Ed.)|January 25, 1986
Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virusJ M Lange, R A Coutinho, W J Krone, et al.
Leukemia|January 1, 1994
Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON)S Daenen, B Löwenberg, P Sonneveld, et al.
The Journal of Biological Chemistry|November 27, 1999
Cyclin D3 regulates proliferation and apoptosis of leukemic T cell linesG J Boonen, B A van Oirschot, A van Diepen, et al.
Pageof 13